Cargando…
elearning for cancer immunotherapy
Advances in cancer immunotherapy witnessed over the last decade with the licensing of numerous immune checkpoint inhibitors have greatly increased the application of this approach to treating advanced cancers. As a result, the number of health care professionals involved in the care of patients rece...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032935/ https://www.ncbi.nlm.nih.gov/pubmed/32153657 http://dx.doi.org/10.3332/ecancer.2020.ed94 |
| _version_ | 1783499565837582336 |
|---|---|
| author | Hill, Samuel L Johnson, Peter WM |
| author_facet | Hill, Samuel L Johnson, Peter WM |
| author_sort | Hill, Samuel L |
| collection | PubMed |
| description | Advances in cancer immunotherapy witnessed over the last decade with the licensing of numerous immune checkpoint inhibitors have greatly increased the application of this approach to treating advanced cancers. As a result, the number of health care professionals involved in the care of patients receiving immunotherapy treatments has grown. While the benefits can be significant, not all patients will experience them and toxicity can profound. elearning tools can help increase knowledge around the mechanisms, benefits and side effects of immunotherapies among clinical staff supporting patients undertaking such treatments. |
| format | Online Article Text |
| id | pubmed-7032935 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Cancer Intelligence |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70329352020-03-09 elearning for cancer immunotherapy Hill, Samuel L Johnson, Peter WM Ecancermedicalscience Editorial Advances in cancer immunotherapy witnessed over the last decade with the licensing of numerous immune checkpoint inhibitors have greatly increased the application of this approach to treating advanced cancers. As a result, the number of health care professionals involved in the care of patients receiving immunotherapy treatments has grown. While the benefits can be significant, not all patients will experience them and toxicity can profound. elearning tools can help increase knowledge around the mechanisms, benefits and side effects of immunotherapies among clinical staff supporting patients undertaking such treatments. Cancer Intelligence 2020-01-16 /pmc/articles/PMC7032935/ /pubmed/32153657 http://dx.doi.org/10.3332/ecancer.2020.ed94 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Hill, Samuel L Johnson, Peter WM elearning for cancer immunotherapy |
| title | elearning for cancer immunotherapy |
| title_full | elearning for cancer immunotherapy |
| title_fullStr | elearning for cancer immunotherapy |
| title_full_unstemmed | elearning for cancer immunotherapy |
| title_short | elearning for cancer immunotherapy |
| title_sort | elearning for cancer immunotherapy |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032935/ https://www.ncbi.nlm.nih.gov/pubmed/32153657 http://dx.doi.org/10.3332/ecancer.2020.ed94 |
| work_keys_str_mv | AT hillsamuell elearningforcancerimmunotherapy AT johnsonpeterwm elearningforcancerimmunotherapy |